Showing results (31-40 of 295) with videos related to
Sort By:
Pageof 30
Antimicrobial Agents and Chemotherapy|July 14, 2001
Variants other than aspartic acid at codon 69 of the human immunodeficiency virus type 1 reverse transcriptase gene affect susceptibility to nuleoside analogsM A Winters, T C MeriganJournal of Immunology (Baltimore, Md. : 1950)|April 1, 1975
Mechanism of the suppressive effect of interferon on antibody synthesis in vivoB R Brodeur, T C MeriganImmunology|September 1, 1994
Relationship of HIV-1 provirus load, CD8+ CD11+ T cells and HIV-1 envelope-specific cytotoxic T lymphocytes in HIV-infected asymptomatic offientsS K Kundu, T C MeriganArchives of Internal Medicine|January 1, 1980
Zoster immune globulin prophylaxis of disseminated zoster in compromised hosts. A randomized trialD A Stevens, T C MeriganJournal of Acquired Immune Deficiency Syndromes|January 1, 1994
Human immunodeficiency virus envelope glycoproteinsT C Merigan, S K KunduThe Journal of Infectious Diseases|May 1, 1995
New virologic tools for the design and analysis of clinical trialsR W Shafer, T C MeriganJournal of Immunology (Baltimore, Md. : 1950)|May 1, 1983
gamma Interferon production appears to predict time of recurrence of herpes labialisA L Cunningham, T C MeriganJournal of Immunology (Baltimore, Md. : 1950)|January 1, 1984
Leu-3+ T cells produce gamma-interferon in patients with recurrent herpes labialisA L Cunningham, T C MeriganThe Journal of Clinical Investigation|May 1, 1972
Interferon, antibody, and other host factors in herpes zosterD A Stevens, T C MeriganPageof 30